118 related articles for article (PubMed ID: 7714788)
21. Human pharmacology of the methamphetamine stereoisomers.
Mendelson J; Uemura N; Harris D; Nath RP; Fernandez E; Jacob P; Everhart ET; Jones RT
Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058
[TBL] [Abstract][Full Text] [Related]
22. The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans.
Foltin RW; Fischman MW
J Pharmacol Exp Ther; 1992 May; 261(2):623-32. PubMed ID: 1578376
[TBL] [Abstract][Full Text] [Related]
23. Flumazenil discrimination by humans under a two-response and a novel-response procedure.
Smith BJ; Bickel WK
J Pharmacol Exp Ther; 1999 Dec; 291(3):1257-68. PubMed ID: 10565850
[TBL] [Abstract][Full Text] [Related]
24. Effects of caffeine on mood and performance: a study of realistic consumption.
Brice CF; Smith AP
Psychopharmacology (Berl); 2002 Nov; 164(2):188-92. PubMed ID: 12404081
[TBL] [Abstract][Full Text] [Related]
25. Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
Makris AP; Rush CR; Frederich RC; Taylor AC; Kelly TH
Exp Clin Psychopharmacol; 2007 Apr; 15(2):123-33. PubMed ID: 17469936
[TBL] [Abstract][Full Text] [Related]
26. Abuse liability assessment of atomoxetine in a drug-abusing population.
Jasinski DR; Faries DE; Moore RJ; Schuh LM; Allen AJ
Drug Alcohol Depend; 2008 May; 95(1-2):140-6. PubMed ID: 18328639
[TBL] [Abstract][Full Text] [Related]
27. Quantifying the molecular structure of behavior: separate effects of caffeine, cocaine, and adenosine agonists on interresponse times and lever-press durations.
Newland MC
Behav Pharmacol; 1997 Feb; 8(1):1-16. PubMed ID: 9832996
[TBL] [Abstract][Full Text] [Related]
28. A dose-response analysis of the subjective, psychomotor and physiological effects of intravenous morphine in healthy volunteers.
Zacny JP; Lichtor JL; Flemming D; Coalson DW; Thompson WK
J Pharmacol Exp Ther; 1994 Jan; 268(1):1-9. PubMed ID: 8301543
[TBL] [Abstract][Full Text] [Related]
29. Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure.
Vukovich MD; Schoorman R; Heilman C; Jacob P; Benowitz NL
Clin Exp Pharmacol Physiol; 2005; 32(1-2):47-53. PubMed ID: 15730434
[TBL] [Abstract][Full Text] [Related]
30. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
[TBL] [Abstract][Full Text] [Related]
31. Effects of nicotine and caffeine, separately and in combination, on EEG topography, mood, heart rate, cortisol, and vigilance.
Gilbert DG; Dibb WD; Plath LC; Hiyane SG
Psychophysiology; 2000 Sep; 37(5):583-95. PubMed ID: 11037035
[TBL] [Abstract][Full Text] [Related]
32. Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans.
Parasrampuria DA; Schoedel KA; Schuller R; Gu J; Ciccone P; Silber SA; Sellers EM
J Clin Pharmacol; 2007 Dec; 47(12):1476-88. PubMed ID: 17962423
[TBL] [Abstract][Full Text] [Related]
33. Effects of dietary caffeine on mood when rested and sleep restricted.
James JE; Gregg ME
Hum Psychopharmacol; 2004 Jul; 19(5):333-41. PubMed ID: 15252825
[TBL] [Abstract][Full Text] [Related]
34. Thermoregulatory effects of caffeine ingestion during submaximal exercise in men.
Dunagan N; Greenleaf JE; Cisar CJ
Aviat Space Environ Med; 1998 Dec; 69(12):1178-81. PubMed ID: 9856543
[TBL] [Abstract][Full Text] [Related]
35. Acute effects of caffeine on heart rate variability in habitual caffeine consumers.
Rauh R; Burkert M; Siepmann M; Mueck-Weymann M
Clin Physiol Funct Imaging; 2006 May; 26(3):163-6. PubMed ID: 16640511
[TBL] [Abstract][Full Text] [Related]
36. Reducing the dose of combined caffeine and ephedrine preserves the ergogenic effect.
Bell DG; Jacobs I; McLellan TM; Zamecnik J
Aviat Space Environ Med; 2000 Apr; 71(4):415-9. PubMed ID: 10766467
[TBL] [Abstract][Full Text] [Related]
37. Effects of repeated doses of caffeine on performance and alertness: new data and secondary analyses.
Hewlett P; Smith A
Hum Psychopharmacol; 2007 Aug; 22(6):339-50. PubMed ID: 17514640
[TBL] [Abstract][Full Text] [Related]
38. Comparing the subjective, psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers.
Zacny JP; Conley K; Marks S
J Pharmacol Exp Ther; 1997 Mar; 280(3):1159-69. PubMed ID: 9067299
[TBL] [Abstract][Full Text] [Related]
39. Low-dose caffeine discrimination in humans.
Griffiths RR; Evans SM; Heishman SJ; Preston KL; Sannerud CA; Wolf B; Woodson PP
J Pharmacol Exp Ther; 1990 Mar; 252(3):970-8. PubMed ID: 2319479
[TBL] [Abstract][Full Text] [Related]
40. Differential contributions of theobromine and caffeine on mood, psychomotor performance and blood pressure.
Mitchell ES; Slettenaar M; vd Meer N; Transler C; Jans L; Quadt F; Berry M
Physiol Behav; 2011 Oct; 104(5):816-22. PubMed ID: 21839757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
